Noncongenital cardiovascular disease (CVD) should be rare among children yet is becoming more prevalent in conjunction with the rise in childhood obesity (1) . Obesity in children is defined as a body mass index (BMI) at or above the 95th percentile for age and sex (2) . Recent estimates from 2007 to 2008 report that 16 .9% of children are obese and 31.6% are overweight in the United States (3, 4) , a concern as many of these children will become obese adults with enhanced risk for CVD (5) (6) (7) (8) . In fact, in 2007 it was predicted that in the United States, the number of additional cardiovascular (CV) events attributable to excess weight in adolescence is expected to be >100,000 by 2035 (9) . Most disturbing, however, are the recent reports that childhood obesity is often accompanied by concurrent CV abnormalities, suggesting the problem is not only one of future or long-term CVD risk but rather, one requiring immediate attention to prevent progressive CV damage in childhood. The goal of this review is to describe the spectrum of CV abnormalities observed in children with obesity, with a specific focus on cardiac and vascular structure and function and autonomic function.
Cardiac Structure and Function
Obesity is associated with increased metabolic demand due to greater adipose tissue and lean mass, increasing blood volume, and as such, increased preload to the heart (10). In addition, vascular alterations impacting arterial stiffness and resistance increase afterload to the heart (10) . Both eccentric and concentric hypertrophy have been noted in adults with obesity and are impacted by the degree and duration of the obesity and whether there is hypertension (11) . Children with obesity present with alterations analogous to that of middle-age adults. Cardiac structure. Studies of children, ranging in sample size from 10 to 233 subjects (Table 1) , have reported that left atrial (12) (13) (14) (15) (16) and left ventricular (LV) (12, 13, (15) (16) (17) (18) (19) (20) (21) (22) dimensions are significantly greater in children with obesity compared with children with a healthy BMI. Several investigations have also reported greater LV mass in children with obesity compared with lean controls (12, 15, 16, (18) (19) (20) (21) (22) (23) (24) (25) , and this has been detected as early as 2 years of age (26) . Greater epicardial fat has also been reported in children with obesity compared with sex-matched children with a healthy BMI, and is positively associated with LV mass (15) . Furthermore, a positive relationship between cardiac size and BMI (14, 24) , insulin resistance (24) , and waistto-height ratio (25) has been reported in children with obesity.
Epicardial fat. Epicardial adipose tissue deposited around the heart between the pericardium and outer wall of the myocardium (27) is proposed to be a CVD risk predictor (28) . Quantification of epicardial adipose tissue by echocardiography is reported to be associated with visceral adipose tissue deposition (29) . Some degree of epicardial fat deposition is observed in healthy subjects, but upper limit values for the healthy range have yet to be established. However, a recent study proposed 4.1 mm as the upper limit cut-off value in children (30) . Epicardial fat deposition is positively associated with insulin resistance (31) , coronary artery disease (32), carotid intima-media thickness (CIMT) (33) , and arterial stiffness (34) in adults and may be a useful clinical tool for assessing CVD risk in children.
Greater epicardial fat deposition has been reported in children with obesity compared with sex-and age-matched children with a healthy BMI (15, 27, 30) . These investigations reported that epicardial fat was positively associated with LV mass (15) and BMI and CIMT (30) in children with obesity but not in lean children. Abaci et al. (30) , reported significantly higher epicardial fat in pubertal lean and obese children compared with pre-pubertal children, illustrating the effects of puberty on epicardial fat deposition. They further demonstrated that epicardial fat deposition of 4.1 mm or greater determined insulin resistance (as assessed by the homeostasis model assessment-estimated insulin resistance [HOMA-IR] index) with 90% sensitivity and 61% specificity, leading these researchers to propose that this cut-off value could be used as a simple, inexpensive, and noninvasive screening tool to predict cardiometabolic dysfunction in obese children (30) . Another study reported that epicardial fat was positively associated with body weight, waist circumference, percent total fat mass as quantified by dual-energy x-ray absorptiometry, visceral and subcutaneous adipose tissue deposition as quantified by magnetic resonance imaging, and systolic blood pressure (27) . Impaired cardiac function. Altered cardiac morphology may be a precursor to impaired cardiac function, or alternatively, cardiac dysfunction may elicit changes in chamber morphology. Studies of children and adolescents with obesity have reported altered cardiac mechanics (Table 1) including diastolic dysfunction (12, 16, 17, 19, 20, 22, 23, (35) (36) (37) (38) and systolic dysfunction at rest (36, 37) and during exercise (22) . The abnormalities in diastolic function, and to a lesser degree, systolic function, are compelling evidence of the association between obesity and CVD in children. Currently, it is unclear how this diminished cardiac function will progress over time, and correlations of such changes in childhood with outcomes in adulthood are lacking. In adults, despite evidence of cardiac enlargement and systolic dysfunction, several studies have found that LV ejection fraction is normal or even supranormal in many obese subjects (39) . However, even with normal ejection fraction, myocardial contractile abnormalities may still exist, and are typically highlighted with more sensitive measures such as tissue Doppler, strain and strain rate analyses (40, 41) . Indeed, digital tagging by magnetic resonance imaging or speckle tracking imaging with echocardiography, have identified reductions in LV strain (13, 21, 38, 42) and strain rate (42) , and right ventricular strain and strain rate (42) in children with obesity. Impaired contractility as demonstrated by these techniques could be missed with more conventional, limited evaluations, and as such the extent of cardiac dysfunction in childhood obesity may be underestimated. Applicability of the tissue Doppler imaging extends to the ability to estimate LV filling pressures in obese subjects. The ratio of early diastolic filling to mitral annular tissue velocity (E/E 0 ) is a well-validated index of pulmonary capillary wedge pressure (43) . This surrogate for filling pressure has been reported to be higher in obese children (12, 18, 19, 23, 37) although still within the normal range and below that shown in children with other CV conditions (44) . The use of tissue Doppler and strain analysis were reported to detect pre-clinical changes in LV systolic function before conventional changes in ejection fraction (45) , deeming these techniques potentially valuable in early detection of obesity-related CV consequences.
Vascular Structure and Function
It is well known that atherogenesis begins in early life. Autopsies on children (2 to 15 years of age) who died from circumstances unrelated to CVD report fatty streaks and fibrous plaque lesions in the aorta (46, 47) . Furthermore, childhood BMI is positively associated with CVD risk in adulthood (6) , suggesting arterial wall damage may begin during childhood. There is evolving evidence that clinical indicators of atherosclerosis such as intima-media thickness, arterial stiffness, and endothelial dysfunction are altered in children with obesity, although the strength of the associations and mechanisms by which these effects are mediated have not been fully elucidated. Carotid intima-media thickness. The assessment of CIMT is a sensitive clinical marker of atherosclerosis and is predictive of CV morbidity and mortality in the general adult population and in at-risk persons (48) . Currently, normative values have been established for adolescents 10 to 20 years of age (49), but not for younger children. Several groups have reported that children and adolescents (ages 10 to 14 years) with obesity (Table 2) have greater CIMT compared with children and adolescents with a healthy BMI (13, 18, (50) (51) (52) (53) (54) (55) (56) (57) . In contrast, others have reported no difference in CIMT, despite impaired endothelial function (58, 59 ) and greater arterial stiffness (59) , in children (ages 8.9 to 12 years) with obesity. Conflicting findings in these studies may be due to differences in the degree of arterial wall remodeling responsible for greater arterial stiffness, and in some cases, it is not advanced to a point that produces intima-media thickening (58) . Further, it is unclear whether age may be a factor in the development of CIMT, as it is in adults (60) . A recent investigation reported that age was a predictor of CIMT in children (61) , but the effect of age could not be distinguished from the effects of pubertal development and exposure to CV risk factors in this study. Furthermore, the severity of obesity and body fat distribution may also contribute to the progression of CIMT (18) . Further research is required to ascertain how obesity, body fat distribution, and/or exposure to CV risk factors affect atherosclerotic progression in children. Vascular age. An interesting clinical application of the use of CIMT is the concept of vascular age. Vascular age evaluates the CIMT measurement against the percentile charts for the race-and sex-matched adult population (62) , and is supported for use to classify CVD risk in adults (63) . After the assessment of 70 children (ages 6 to 19 years; 89% European; 49% male) with obesity and atherosclerosispromoting risk factors (dyslipidemia, hypertension, insulin resistance, and smoke exposure), Le et al. (64) reported that 75% of these children had advanced vascular age, similar to what would be expected for a 45-year-old adult. The average CIMT was 0.07 mm higher in the children with advanced vascular age compared with children categorized as normal vascular age, which is greater than the estimated 0.01 mm per year increase in CIMT reported for age-related progression in healthy adults (64) . With the establishment of normative values in children, vascular age could serve as an effective clinical tool for predicting CVD risk in children. Arterial stiffness. It is well established that greater vascular stiffness is associated with increased CVD risk in adults (65) . An elastic vascular system reduces cardiac demand (66) , increases coronary artery perfusion (67) , and is associated with reduced atherosclerotic progression (68) . Central pulse wave velocity (PWV) is most strongly correlated with CVD (69) and is predictive of both CV morbidity and allcause mortality in adults (70) . Reference values of aortic PWV have recently been reported for healthy children ages 3 to 18 years in which aortic stiffness remains stable up to approximately 8 years of age, and then gradually increases in both sexes with age (71) . Arterial compliance increases with age as arteries become larger during childhood growth and development (72) , and may temper age-associated increases in arterial stiffness in young subjects (73) .
Greater arterial stiffness has been reported in children with obesity (Table 2) at the carotid artery (18, 53, 59 ) and in central measures of PWV (13, 36, 52, (74) (75) (76) . In addition, we and others (17, 36, 77) have reported abnormal biophysical properties in the aorta of children with obesity, indicating loss of aortic elasticity. The effects of obesity on arterial properties has also been demonstrated in the pulmonary artery (36) . Increased pulmonary stiffness is thought to play a role in the development and progression of pulmonary hypertension, and can be identified before any clinical evidence of pressure elevations (78) . In contrast to the reports that show increased arterial stiffness in children with obesity, some recent investigations have reported lower measures of arterial stiffness (79, 80) or increased arterial compliance (81, 82) in children with obesity compared with healthy BMI controls. Interestingly, in some of these studies, the enhanced arterial properties in children with obesity was accompanied by cardiometabolic dysfunction such as elevated blood pressure (80, 81) , greater insulin resistance, and elevated plasma triglycerides, total cholesterol, and C-reactive protein concentrations (82) . Technical considerations may be responsible for these discrepant results. The reduced peripheral PWV (80) and increased arterial compliance (81, 82) in children with obesity may be a reflection of increasing arterial diameter, which occurs naturally during development, and may be altered (greater) in children with obesity. The increased arterial diameters and/or large vessel elasticity that occurs with growth and development may be adequate to compensate for increased arterial pressures (71) . When tension in the aortic wall surpasses the point of natural adaptation, aortic stiffness would subsequently rise, differentiating arterial stiffness in children with and without obesity. In support of this, Dangardt et al. (80) reported lower carotid-to-radial PWV in 14-year-old obese adolescents compared with age-matched lean adolescents; however, in a recent follow-up, they reported that at age 19 years of age, those with obesity now had a higher PWV compared with those with a healthy BMI (83) . These researchers found that over the 5-year study period, arterial stiffness increased 25% in adolescents with obesity compared with 3% in adolescents with a healthy BMI. Furthermore, the degree of increase in arterial stiffness at the 5-year follow-up was positively associated with BMI zscore at baseline. Thus, it may be difficult to disassociate the natural adaptations that occur with growth from the pathological developments of obesity on arterial stiffness during adolescence.
An important consideration when interpreting arterial stiffness and compliance findings are that many do not control for sex and pubertal status, which are important factors known to influence arterial wall properties (84) . Developmental adaptations in systemic compliance and central and peripheral arterial stiffness during the prepubertal, pubertal, and post-pubertal stages have been described. For example, pre-pubertal girls display greater arterial stiffness and lower systemic compliance than boys; however, post-pubertal girls display similar compliance and central artery stiffness and lower peripheral arterial stiffness than boys (84) , likely the result of differences in sex steroid hormones, such as estrogens, which are known to influence arterial structure and function (85) . Furthermore, a recent investigation reported that the steep increase in PWV, which occurs normally during development, was observed almost 2 years earlier in girls than in boys (71) . As such, caution must be made when comparing findings from studies conducted in children that differ in terms of sex and pubertal stage, and adjustments for both of these factors should be considered in the data analyses. Endothelial function. The vascular endothelium plays a key role in the progression of atherosclerosis (86) . Damage to the endothelium, assessed by brachial artery flowmediated dilation (FMD), is an early clinical indicator of atherosclerosis and vascular damage (87, 88) . A recent metaanalysis suggested that FMD might only be a useful indicator of CVD in populations at low risk (89) . Considering many children with obesity may not present with additional metabolic or clinical risk factors, FMD may be useful in identifying those children with early signs of atherosclerotic development.
Several studies ( Table 2 ) have reported that children with obesity have lower FMD compared with children with a healthy BMI (50) (51) (52) (54) (55) (56) 58, 59, (90) (91) (92) (93) (94) (95) . Only 2 studies have reported similar FMD in children with obesity compared with children with a healthy BMI (13, 82) . There is some evidence to suggest that the presence of cardiometabolic risk factors affect the relationship between obesity and FMD in children. For example, Pena et al. (95) reported a negative relationship between low-density lipoprotein cholesterol and FMD (95) . Furthermore, Bhattacharjee et al. (93) demonstrated that the degree of delay in post-ischemia recovery was positively correlated with the degree of dyslipidemia in nonhypertensive children with and children without obesity. In the later study, the children with obesity were free of obstructive sleep apnea, which is known to interact with obesity to amplify CV morbidity (96) . Autonomic function. Impaired cardiac autonomic function is related to all-cause mortality and sudden cardiac events in adults (97) . Specifically, a reduction in vagal activity has been associated with the development of CVD and mortality (98) , and baroreflex sensitivity is considered a prognostic factor in cardiology (99) . Furthermore, depressions in autonomic activity may precede the overt signs of CVD (100), deeming autonomic assessment a potential useful clinical tool in early identification of children and youth at risk.
Several reports have provided evidence of autonomic dysfunction in children with obesity (101-110) ( Table 3) . Indications of reduced vagal or parasympathetic activity of heart rate variability are most commonly reported (102) (103) (104) (105) 110) with some reports of a concurrent decrease in sympathetic activity (105, 108) . The low frequency to high frequency ratio may also be increased in children with obesity (102, 103, 107, 110) , a marker of sympathovagal imbalance (111) . In addition, diminished baroreflex sensitivity has also been reported (106, 109) . Given that the baroreflex is important for regulating blood pressure (112) , the assessment of cardiac baroreceptor sensitivity incorporates both afferent and efferent signaling in cardiac vagal activity and may be more sensitive than heart rate variability to identify autonomic dysfunction in children (106, 113) .
Some investigations have categorized children as lean (healthy BMI), overweight (BMI !85th percentile for age and sex), and obese. Two independent studies have reported 
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Cardiovascular Effects of Childhood Obesity autonomic distinctions between lean and obese children, with overweight children presenting similar autonomic indices compared with lean children (103, 106) . Furthermore, in a study of children (n ¼ 91) at 9 years of age with obesity, a positive relationship between BMI percentile and impaired autonomic function was reported (107) . In healthy children and adolescents, puberty is reported to influence autonomic function, although a recent study in obese children and adolescents controlled for pubertal status and determined baroreflex function is independent of age and sex (106) .
Mechanisms of Cardiovascular Dysfunction in Childhood Obesity
The mechanisms responsible for CV dysfunction in children with obesity are difficult to ascertain in the absence of longitudinal data. The cascade of events leading to CVD may vary in response to genetic and environmental factors as well as the presence or absence of other comorbidities such as hypertension or dyslipidemia (39) . We have summarized some of the important factors, which have been identified (Fig. 1) ; however, many of the specific mechanisms and interactions are incompletely understood in children and likely involves a complex interaction between the presented factors. For example, autonomic function is sensitive to changes in adiposity (114) , yet may continue to be altered as atherosclerosis-related structural changes in large arteries impede vagal input (115) . Furthermore, metabolic dysfunction accompanying obesity, such as leptin or insulin resistance, may alter the sympathovagal balance via effects on vascular smooth muscle (116) . However, the relevance of these factors during childhood obesity remains to be determined.
It has been proposed that the duration of obesity is a major factor that determines the likelihood of developing systolic dysfunction and heart failure (14). Indeed obesity in older individuals appears to pose less of a mortality risk than it does in younger subjects (117) . Given the structural and functional changes have been reported in obese children, the reports of increased morbidity and mortality with obesity in adolescence (118) may be underestimated. Longitudinal studies in children with obesity are required to delineate the progression of CV abnormalities and the long-term health consequences.
Cardiovascular Effects of Interventions in Childhood Obesity
Indications for clinical interventions to prevent CVD in overweight and obese children are not well defined. Current clinical guidelines advocate lifestyle, dietary, and exercise interventions for the prevention and management of obesity and use BMI as an outcome measure of treatment success (119, 120) , with more aggressive approaches such as pharmacotherapy and bariatric surgery considered for severely obese adolescents with serious complications who have failed other, more conventional therapies (121) . The efficacy of the various obesity treatment options for children is a complex topic and may be reviewed elsewhere (122, 123) . The most common interventions for childhood obesity include eating a healthy diet, increasing moderate-to-vigorous physical activity, and reducing sedentary activities.
Exercise programs have positive effects on BMI and measures of adiposity over short-term (i.e., 10 weeks) (124) and moderate (4 months) timeframes (125) . However, not all studies have demonstrated reductions in BMI despite other beneficial outcomes such as improved endothelial function (126, 127) . Exercise may alter body composition although body weight remains constant (128); thus, BMI as a primary outcome measure may underestimate the effectiveness of the intervention, particularly with respect to CV risk. Reductions in central adiposity, determined using dualenergy x-ray absorptiometry, were reported after only 8 weeks of circuit training despite no change in BMI or waist circumference (129) , highlighting the potential underestimation of an intervention's success when BMI is the primary outcome measure. Interventions designed to assess changes in CV structure and/or function are limited. Reports of improved cardiac function (37) and vascular function (91, 126, (129) (130) (131) (132) with exercise, as well as improved diastolic function after 6 months of dietary intervention (133) , are promising. Exerciseinduced improvements in FMD in children with obesity are shown to be reversed after only 6 weeks of inactivity (126, 129) , advocating exercise as a useful method of both prevention and treatment. Given the energy demands on the growing body in youth, vigorous physical activity has been proposed to be more effective in the prevention of obesity than restriction of energy intake (134) . In contrast with these results, 1 study reported reductions in BMI, waist circumference, systolic blood pressure, and low-density lipoprotein cholesterol after 10 weeks of aerobic or circuit training (combination of aerobic and resistance exercises), in the absence of improved arterial stiffness (124) . Another study found reductions in body fat and BMI that were not accompanied by improved endothelial function (135) . In morbidly obese adolescents, bariatric surgery improved cardiac geometry and diastolic function (assessed at 10 AE 3 months post-operative) (136) . Further, bariatric surgery was reported to be associated with a decrease in epicardial fat (137) . Longitudinal randomized control studies with long-term follow-up are required to evaluate the most effective interventions.
Clinical Considerations
The research to date illustrates that obesity during childhood and adolescence is associated with various measurable alterations in CV structure and function. Interpretation of research findings is complex, given the variation in the type and number of CV risk factors present in children with obesity. Our understanding of the cumulative effects of multiple risk factors, the weighted importance of the risk factor, and the effect of the length of exposure to the risk factors is limited.
In the clinical setting, the measures discussed in this review are not routinely performed, with the exception of quantifying Cote et al. October 8, 2013 October 8, :1309 Cardiovascular Effects of Childhood Obesity LV mass. Thus, the extent of obesity-related CV changes are likely under-recognized and therefore under-managed. A standardized clinical approach to the CV evaluation of children with obesity is required. Importantly, this approach should include early detection and evaluation of subclinical cardiac dysfunction, given the potential for reversibility. However, incorporating these assessments into clinical practice is challenging when specialized equipment and/or personnel may be required. Furthermore, there is a lack of adequate normative data with which to compare the individual patient, and acquisition of these data is paramount to establishing clinical guidelines.
For the clinician, monitoring CV biomarkers is an attractive option for individual patient care as lipid screening is already part of routine assessment and monitoring in children with obesity. Biomarkers may indicate the progression of disease but causality cannot be assumed. Despite the interest in the use of biomarkers to assess children at risk, a recent review of CVD biomarkers in children concluded there are insufficient data to recommend the use of any 1 biomarker in screening pediatric populations for CVD (138) .
Future Directions
Considering the effects of aging on arterial stiffness and LV relaxation patterns, obesity-related advancements in vascular age and cardiac dysfunction during childhood will accelerate the progression of CVD (12) . What is most apparent from the collective findings in this review is that childhood obesity not only increases CV risk in adulthood, but is also associated with CV damage during childhood. As such, there is an urgent need for prevention and treatment programs designed specifically for children with obesity. Given the paucity of interventional studies in this population, the indications for intervention and the most effective therapy for obese children with CV abnormalities have not been adequately elucidated.
To advance our understanding of the CVD risk in children with obesity, long-term comprehensive studies are required that will provide standard normative values on measures of CV function throughout childhood and take into account adaptive changes associated with growth and development. These normative values are required to distinguish the adaptive changes that occur during healthy development from the maladaptive or pathological changes occurring as a consequence of obesity. Furthermore, identifying biomarkers associated with adaptive changes in CV function through growth and development and how these biomarkers change with obesity-related CVD may provide alternative cost-effective measures that can be used to screen children for CV dysfunction. In addition, future research should incorporate more clinically important endpoints for evaluating the success of an intervention, such as body composition in place of BMI or weight loss. Despite the costs associated with imaging, percentage of body fat quantified by dual-energy x-ray absorptiometry, or magnetic resonance imaging to quantify visceral adiposity and epicardial fat, will provide a more valid assessment of the effectiveness of an intervention, in addition to depicting CV risk more accurately than traditional anthropometrics.
Conclusions
Early identification of cardiac dysfunction in children with obesity is warranted to mitigate long-term complications. Longitudinal studies designed to track the progression of CVD as well as those evaluating comprehensive treatment interventions will guide clinical assessment choices and ultimately permit risk stratification and optimal treatment with evidence-based care guidelines. 
